TrialVaccine2009

A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults.

Issaka Sagara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.